Frank Rimerman Advisors LLC Buys Shares of 18,938 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Frank Rimerman Advisors LLC purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 18,938 shares of the pharmacy operator’s stock, valued at approximately $170,000.

Other large investors have also made changes to their positions in the company. Iron Horse Wealth Management LLC increased its position in Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 1,300 shares in the last quarter. Blue Trust Inc. raised its position in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the period. Continuum Advisory LLC grew its position in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the period. Eastern Bank acquired a new stake in Walgreens Boots Alliance during the third quarter worth about $33,000. Finally, Strategic Investment Solutions Inc. IL purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter worth about $34,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 1.0 %

NASDAQ WBA opened at $9.35 on Wednesday. The company has a market capitalization of $8.08 billion, a price-to-earnings ratio of -0.93, a price-to-earnings-growth ratio of 1.20 and a beta of 0.70. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 12 month low of $8.22 and a 12 month high of $27.05. The company’s fifty day moving average price is $9.26 and its two-hundred day moving average price is $12.61.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same period last year, the firm earned $0.67 earnings per share. The company’s revenue for the quarter was up 5.9% compared to the same quarter last year. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.54 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 10.70%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on WBA shares. Barclays increased their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. TD Cowen reduced their target price on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. UBS Group raised their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Evercore ISI upped their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Finally, Jefferies Financial Group reduced their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.